Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus (Q45784460)

16 December 2017

title

Mycosis fungoides: expression of C-myc p62 p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus (English)

1 reference

16 December 2017

0 references

1 reference

Kanavaros P

1

1 reference

16 December 2017

Ioannidou D

2

1 reference

16 December 2017

Tzardi M

3

1 reference

16 December 2017

Datseris G

4

1 reference

16 December 2017

Katsantonis J

5

1 reference

16 December 2017

Delidis G

6

1 reference

16 December 2017

Tosca A

7

1 reference

16 December 2017

publication date

1 September 1994

1 reference

16 December 2017

Pathology, Research and Practice

published in

1 reference

16 December 2017

volume

190

1 reference

16 December 2017

issue

8

1 reference

16 December 2017

page(s)

767-774

1 reference

16 December 2017

Functional role for c-myc in mitogenic response to platelet-derived growth factor

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Correlation of proliferative activity in breast tissue using PCNA/cyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of a cellular oncogene during liver regeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Growth factors: Mechanism of action and relation to oncogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Bcl-2 functions in an antioxidant pathway to prevent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of c-myc and bcl-2 oncogene products in Reed-Sternberg cells independent of presence of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

High incidence of EBV genome in CD30-positive non-Hodgkin's lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of c-myc p62 Protein in Non-Hodgkin's Lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Viral latency and transformation: the strategy of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Cancer. p53, guardian of the genome

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

The p53 tumour suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18)

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Nucleolar organizer regions (NORs) staining and proliferating cell nuclear antigen (PCNA) immunostaining in mucosa-associated lymphoid tissue (MALT) gastric lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Two human c-onc genes are located on the long arm of chromosome 8.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Prevalence of epstein‐barr virus DNA in different T‐cell lymphoma entities in a European population

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Analysis of Epstein-Barr viral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Epstein-Barr virus (EBV) in enteropathy-associated T-cell lymphoma (EATL).

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Epstein-Barr virus (EBV) genomes and EBV-encoded latent membrane protein (LMP) in pulmonary lymphomas occurring in nonimmunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

p53 expression in lymphatic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Peripheral T-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Epstein-Barr virus: an aetiological factor in cutaneous lymphoproliferative disorders?

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Mycosis fungoides: evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages.

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Towards a better understanding of cellular events in Mycosis fungoides: an immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

P53 protein expression in lymphomas and reactive lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Fine-needle aspiration of non-Hodgkin's lymphoma. Southern blot analysis for antigen receptor, bcl-2, and c-myc gene rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0344-0338%2811%2980423-1

7 January 2021

10.1016/S0344-0338(11)80423-1

Identifiers

DOI

0 references

1 reference

16 December 2017